14 November 2019
Early results of a new pilot study conducted by researchers from the International Agency for Research on Cancer (IARC) and partners suggest that an innovative device provides an effective method to treat cervical pre-cancers in low- and middle-income countries. The results were published today in The Lancet Oncology
Dr Partha Basu, Head of the IARC Screening Group and an author of the study, describing the trial and the results
Dr Walter Prendiville, Senior Visiting Scientist at IARC, an author of the study, and a key advisor in the development of the thermal ablation device, describing why the device was developed and the advantages it offers compared with current treatment options
